Pricing Log in Create free account

Pasithea Therapeutics Corp. (KTTA) vs Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX)

Pasithea Therapeutics Corp. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are both Biotechnology companies. Pasithea Therapeutics Corp. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are of similar size ($18.5M and $17.4M). Across the 9 metrics below, Pasithea Therapeutics Corp. leads on 5 and Quoin Pharmaceuticals, Ltd. Sponsored ADR on 4.

Valuation

Metric KTTA QNRX Biotechnology median
P/E n/m n/m 10.60
P/S 38.26 n/m 9.40
P/B 0.37 2.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.17 n/m 0.66
EV/Sales (55.79) n/m 9.02
Earnings yield (254.86%) (331.86%) (32.88%)
Free cash flow yield (94.76%) (27.69%) (23.13%)

Profitability

Metric KTTA QNRX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.49%) (575.73%) (51.96%)
Return on assets (61.97%) (178.77%) (46.06%)
Return on invested capital (367.46%) 0.00% 0.00%

Growth

Metric KTTA QNRX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 77.07% 77.84% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KTTA QNRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 26.25 1.76 4.97
Net debt to EBITDA 2.74 1.16 1.01

Dividend

Metric KTTA QNRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KTTA QNRX Biotechnology median
Market cap 17.38m 18.48m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack